Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196391 · ClinicalTrials.gov registry record · Phase 2
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
A Phase 2 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
NCT00196391 is a Phase 2 study that has completed, run by Duramed Research. The registered enrollment target is 180 participants.
The verdict
NCT00196391, a Phase 2 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
Study Summary
This is a multicenter trial to compare the effectiveness of 4 doses of DR-2021 with placebo and oral micronized progesterone in inducing withdrawal bleeding in women with secondary amenorrhea.
Interventions
- DRUG DR-2021a
- DRUG DR-2021b
- DRUG DR-2021c
- DRUG DR-2021d
- DRUG DR-2021e
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196391
The ClinicalTrials.gov registry entry for NCT00196391 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which DR-2021a is the first listed.
NCT00196391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00196391 about?
NCT00196391 is a clinical study titled "A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea". This is a multicenter trial to compare the effectiveness of 4 doses of DR-2021 with placebo and oral micronized progesterone in inducing withdrawal bleeding in women with secondary amenorrhea.
What is the current status of trial NCT00196391?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2005-09. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00196391?
The interventions under investigation include: DR-2021a (DRUG), DR-2021b (DRUG), DR-2021c (DRUG), DR-2021d (DRUG), DR-2021e (DRUG).
Who is sponsoring clinical trial NCT00196391?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.